Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3058 (LINC03058) is a human long intergenic non-coding RNA (lincRNA), meaning it is an RNA gene transcribed from an intergenic region that does not overlap known protein-coding genes and does not code for a protein[1][3][5][7]. LincRNAs are typically longer than 200 nucleotides. They are part of the larger family of long non-coding RNAs (lncRNAs) and act mainly through RNA-based mechanisms such as chromatin remodeling, stabilization of RNA transcripts, transcriptional regulation, and modulation of genome architecture[1][3][5]. The specific biological role and disease associations of LINC03058 are not characterized in the literature, consistent with most annotated lincRNAs for which functional evidence remains limited[5]. Some lincRNAs have established roles in gene regulation and are implicated in human diseases, but no direct evidence exists for LINC03058 as a therapeutic target or disease biomarker[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3058 (LINC03058).